Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 70

1.

Acute Necrotizing Encephalopathy in Children: a Long Way to Go.

Lee YJ, Hwang SK, Kwon S.

J Korean Med Sci. 2019 May 20;34(19):e143. doi: 10.3346/jkms.2019.34.e143.

2.

Relationship between systolic hypertension assessed by 24-hour ambulatory blood pressure monitoring and aortic diameters in young women with Turner syndrome.

Lee YJ, Kim SM, Lee YA, Kim GB, Shin CH, Yang SW.

Clin Endocrinol (Oxf). 2019 Apr 18. doi: 10.1111/cen.13995. [Epub ahead of print]

PMID:
31001842
3.

A family with a mild form of congenital nystagmus and optic disc coloboma caused by a novel PAX6 mutation.

Lee B, Choi DG, Chun BY, Oh EH, Lee YJ, Kim UK, Park JS.

Gene. 2019 Apr 12;705:177-180. doi: 10.1016/j.gene.2019.04.035. [Epub ahead of print]

PMID:
30986449
4.

The Role of ZNF143 in Breast Cancer Cell Survival Through the NAD(P)H Quinone Dehydrogenase 1⁻p53⁻Beclin1 Axis Under Metabolic Stress.

Paek AR, Mun JY, Jo MJ, Choi H, Lee YJ, Cheong H, Myung JK, Hong DW, Park J, Kim KH, You HJ.

Cells. 2019 Mar 30;8(4). pii: E296. doi: 10.3390/cells8040296.

5.

The Korean undiagnosed diseases program: lessons from a one-year pilot project.

Kim SY, Lim BC, Lee JS, Kim WJ, Kim H, Ko JM, Kim KJ, Choi SA, Kim H, Hwang H, Choi JE, Cho A, Moon J, Seong MW, Park SS, Lee YJ, Kim YO, Kim JS, Kim WS, Kwon YS, Park JD, Ahn Y, Hwang JY, Park HY, Lee Y, Choi M, Chae JH.

Orphanet J Rare Dis. 2019 Mar 20;14(1):68. doi: 10.1186/s13023-019-1041-5.

6.

The relationship of urinary 3-phenoxybenzoic acid concentrations in utero and during childhood with adiposity in 4-year-old children.

Lee KS, Lee YA, Lee YJ, Shin CH, Lim YH, Hong YC.

Environ Res. 2019 May;172:446-453. doi: 10.1016/j.envres.2019.02.037. Epub 2019 Feb 26.

PMID:
30831434
7.

Diagnostic usefulness of arterial spin labeling in MR negative children with new onset seizures.

Lee SM, Kwon S, Lee YJ.

Seizure. 2019 Feb;65:151-158. doi: 10.1016/j.seizure.2019.01.024. Epub 2019 Jan 27.

PMID:
30718217
8.

Efficacy and tolerability of adjunctive perampanel treatment in children under 12 years of age with refractory epilepsy.

Yun Y, Kim D, Lee YJ, Kwon S, Hwang SK.

Korean J Pediatr. 2018 Dec 26. doi: 10.3345/kjp.2018.06863. [Epub ahead of print]

9.

Influence of CYP2D6 genetic polymorphism on pharmacokinetics of active moiety of tolterodine.

Byeon JY, Lee CM, Lee YJ, Kim YH, Kim SH, Jung EH, Chae WK, Lee YJ, Jang CG, Lee SY.

Arch Pharm Res. 2019 Feb;42(2):182-190. doi: 10.1007/s12272-018-1099-y. Epub 2018 Dec 12.

PMID:
30542809
10.

CYP2D6 allele frequencies in Korean population, comparison with East Asian, Caucasian and African populations, and the comparison of metabolic activity of CYP2D6 genotypes.

Byeon JY, Kim YH, Lee CM, Kim SH, Chae WK, Jung EH, Choi CI, Jang CG, Lee SY, Bae JW, Lee YJ.

Arch Pharm Res. 2018 Sep;41(9):921-930. doi: 10.1007/s12272-018-1075-6. Epub 2018 Sep 6.

PMID:
30191460
11.

The influences of CYP2C9*1/*3 genotype on the pharmacokinetics of zolpidem.

Byeon JY, Kim YH, Kim SH, Lee CM, Jung EH, Chae WK, Jang CG, Lee SY, Lee YJ.

Arch Pharm Res. 2018 Sep;41(9):931-936. doi: 10.1007/s12272-018-1070-y. Epub 2018 Sep 3.

PMID:
30178440
12.

Evaluation of medication use and pharmacy services for visually impaired persons: Perspectives from both visually impaired and community pharmacists.

Lee BH, Lee YJ.

Disabil Health J. 2019 Jan;12(1):79-86. doi: 10.1016/j.dhjo.2018.07.012. Epub 2018 Aug 16.

PMID:
30170955
13.

Physiologically based pharmacokinetic modelling of atomoxetine with regard to CYP2D6 genotypes.

Kim SH, Byeon JY, Kim YH, Lee CM, Lee YJ, Jang CG, Lee SY.

Sci Rep. 2018 Aug 17;8(1):12405. doi: 10.1038/s41598-018-30841-8.

14.

Effects of genetic polymorphisms of CYP2C19 on the pharmacokinetics of zolpidem.

Byeon JY, Kim YH, Kim SH, Lee CM, Jung EH, Chae WK, Jang CG, Lee SY, Lee YJ.

Arch Pharm Res. 2018 Aug;41(8):861-866. doi: 10.1007/s12272-018-1065-8. Epub 2018 Aug 16.

PMID:
30117082
15.

Effects of CYP2C19 and CYP3A5 genetic polymorphisms on the pharmacokinetics of cilostazol and its active metabolites.

Lee HI, Byeon JY, Kim YH, Lee CM, Choi CI, Jang CG, Bae JW, Lee YJ, Lee SY.

Eur J Clin Pharmacol. 2018 Nov;74(11):1417-1426. doi: 10.1007/s00228-018-2522-5. Epub 2018 Jul 24.

PMID:
30039199
16.

Effects of diltiazem, a moderate inhibitor of CYP3A4, on the pharmacokinetics of tamsulosin in different CYP2D6 genotypes.

Byeon JY, Lee YJ, Kim YH, Kim SH, Lee CM, Bae JW, Jang CG, Lee SY, Choi CI.

Arch Pharm Res. 2018 May;41(5):564-570. doi: 10.1007/s12272-018-1030-6. Epub 2018 May 4.

PMID:
29728928
17.

Effect of the CYP2D6*10 allele on the pharmacokinetics of clomiphene and its active metabolites.

Kim MJ, Byeon JY, Kim YH, Kim SH, Lee CM, Jung EH, Chae WK, Lee YJ, Jang CG, Lee SY, Choi CI.

Arch Pharm Res. 2018 Mar;41(3):347-353. doi: 10.1007/s12272-018-1005-7. Epub 2018 Mar 7.

PMID:
29516347
18.

A novel CACNA1A mutation associated with episodic ataxia 2 presenting with periodic paralysis.

Park D, Kim SH, Lee YJ, Song GJ, Park JS.

Acta Neurol Belg. 2018 Mar;118(1):137-139. doi: 10.1007/s13760-018-0895-y. Epub 2018 Feb 13. No abstract available.

PMID:
29442233
19.

Evaluation of pharmacokinetic, pharmacodynamic, efficacy, and safety data of low-dose ticagrelor versus standard dose in East Asians: a systematic review.

Lee YJ, Kim H, Choi J, Lee BH, Lee SY.

Ther Clin Risk Manag. 2018 Jan 8;14:83-93. doi: 10.2147/TCRM.S152276. eCollection 2018. Review.

20.

Inhibition of salivary secretion by tolterodine transdermal patch.

Byeon JY, Kim YH, Kim SH, Lee CM, Choi CI, Bae JW, Jang CG, Lee SY, Lee YJ.

Arch Pharm Res. 2017 Dec;40(12):1455-1463. doi: 10.1007/s12272-017-0988-9. Epub 2017 Nov 20.

PMID:
29159581

Supplemental Content

Loading ...
Support Center